These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7905113)

  • 1. Treatment of idiopathic membranous nephropathy.
    Piccoli A; Pillon L
    Lancet; 1994 Jan; 343(8892):291-2. PubMed ID: 7905113
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C; Zucchelli P; Passerini P; Cagnoli L; Cesana B; Pozzi C; Pasquali S; Imbasciati E; Grassi C; Redaelli B
    N Engl J Med; 1989 Jan; 320(1):8-13. PubMed ID: 2642605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.
    Ponticelli C; Altieri P; Scolari F; Passerini P; Roccatello D; Cesana B; Melis P; Valzorio B; Sasdelli M; Pasquali S; Pozzi C; Piccoli G; Lupo A; Segagni S; Antonucci F; Dugo M; Minari M; Scalia A; Pedrini L; Pisano G; Grassi C; Farina M; Bellazzi R
    J Am Soc Nephrol; 1998 Mar; 9(3):444-50. PubMed ID: 9513907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
    Ponticelli C; Zucchelli P; Passerini P; Cesana B
    N Engl J Med; 1992 Aug; 327(9):599-603. PubMed ID: 1640953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete remission of nephrotic syndrome after steroid-chlorambucil in a previous failed short-term steroidal treatment of a primary membranous nephropathy.
    Ardiles LG; Mezzano SA
    Clin Nephrol; 1996 Jun; 45(6):423. PubMed ID: 8793243
    [No Abstract]   [Full Text] [Related]  

  • 6. 20 years after methylprednisolone/chlorambucil treatment in idiopathic membranous nephropathy stage II-III with nephrotic syndrome.
    Polenakovic M; Grcevska L; Dzikova S
    Prilozi; 2006 Dec; 27(2):5-12. PubMed ID: 17211287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy.
    Ponticelli C; Zucchelli P; Passerini P; Cesana B; Locatelli F; Pasquali S; Sasdelli M; Redaelli B; Grassi C; Pozzi C
    Kidney Int; 1995 Nov; 48(5):1600-4. PubMed ID: 8544420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
    Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B
    Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression.
    Hebert LA; Rovin BH; Agarwal AK; Spetie DN
    Am J Kidney Dis; 2005 Apr; 45(4):788-9; author replyy 789-90. PubMed ID: 15806488
    [No Abstract]   [Full Text] [Related]  

  • 10. Membranous nephropathy--still a treatment dilemma.
    Cameron JS
    N Engl J Med; 1992 Aug; 327(9):638-9. PubMed ID: 1640957
    [No Abstract]   [Full Text] [Related]  

  • 11. A difficult trade off for adults with membranous nephropathy.
    BMJ; 2013 Jan; 346():f248. PubMed ID: 23325868
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of immunosuppressive treatment in patients with membranous nephropathy and renal insufficiency.
    Wetzels JF; Reichert LJ
    Kidney Int Suppl; 1997 Oct; 61():S63-6. PubMed ID: 9328969
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppression for membranous nephropathy.
    Lancet; 1988 Dec; 2(8624):1361-2. PubMed ID: 2904068
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of bronchial adenocarcinoma 11 years after the onset of membranous nephropathy associated with chlorambucil therapy.
    Polenaković M; Grcevska L
    Nephron; 1995; 69(3):335-6. PubMed ID: 7753270
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy for idiopathic membranous nephropathy: tailoring the choice by decision analysis.
    Piccoli A; Pillon L; Passerini P; Ponticelli C
    Kidney Int; 1994 Apr; 45(4):1193-202. PubMed ID: 8007591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of artificial neural networks in estimating predictive factors and therapeutic efficacy in idiopathic membranous nephropathy.
    Naumovic R; Furuncic D; Jovanovic D; Stosovic M; Basta-Jovanovic G; Lezaic V
    Biomed Pharmacother; 2010 Nov; 64(9):633-8. PubMed ID: 20888177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic membranous glomerulonephritis in the elderly.
    Bizzarri D; Imperiali P; Duranti E; Sasdelli M
    Contrib Nephrol; 1993; 105():65-70. PubMed ID: 8252873
    [No Abstract]   [Full Text] [Related]  

  • 18. Retreatment of membranous nephropathy with steroids and chlorambucil after initial unresponsiveness to alternate-day prednisone.
    Tietjen DP
    Clin Nephrol; 1990 Mar; 33(3):152. PubMed ID: 2323113
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment and long-term follow-up of patients with stage II to III idiopathic membranous nephropathy.
    Polenakovik MH; Grcevska L
    Am J Kidney Dis; 1999 Nov; 34(5):911-7. PubMed ID: 10561149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of membranous nephropathy with prednisolone and chlorambucil.
    Mavromatidis C; Spaia S; Christidou F; Vayonas G
    Lancet; 1989 May; 1(8645):1015. PubMed ID: 2565486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.